Antioxidant and Understanding the Anticancer Properties in Human Prostate and Breast Cancer Cell Lines of Chemically Characterized Methanol Extract from Berberis hispanica Boiss. & Reut

Abstract

The current research was conducted to investigate the chemical profile, antiproliferative, and antioxidant activities of methanol extracts obtained by two different methods including maceration and Soxhlet from Berberis hispanica Boiss. & Reut. Antiproliferative activities were evaluated by the MTT (3-(4, 5-dimethylthiazolyl-2)-2, 5-diphenyltetrazolium bromide) assay in four human cancer cell lines including prostate (LnCap and 22 RV1) and breast cancer (MDA-MB-231 and MCF7). The antioxidant power was evaluated by DPPH ((2,2-diphenyl-1-picryl-hydrazyl-hydrate), ABTS (2,2′-azino-bis(3-ethylbenzothiazoline-6-sulfonic acid), and FRAPS (Ferric reducing antioxidant power) tests. The chemical composition was conducted by gas chromatography-mass spectrometry (GC-MS) after methylation. Total phenolic and flavonoid contents were assessed using the Folin–Ciocalteu method. The phytochemical analysis showed that the tested extracts possessed inserting potentially active compounds. The MTT test revealed that both extracts (maceration and Soxhlet) reduced cell viability in all cell lines tested. In breast cancer cell lines MDA-MB-231 and MCF-7, the IC₅₀ values obtained by maceration were 16.55 ± 0.58 and 17.95 ± 0.58 µg/mL, respectively. These values were slightly lower than those obtained with the Soxhlet extract toward MDA-MB-231 (19.93 ± 0.74 µg/mL) and MCF-7 (20.22 ± 0.89 µg/mL). Regarding prostate cancer cells 22 RV and LnCap, the IC₅₀ values obtained by maceration extract (22 RV: 11.75 ± 0.35 µg/mL; LnCap: 11.91 ± 0.54 µg/mL) were also slightly lower than those obtained with Soxhlet (22 RV: 13.47 ± 0.52 µg/mL; LnCap: 19.64 ± 1.05 µg/mL). The antioxidant activity showed that the studied extracts had considerable antioxidant activity (DPPH, FRAP, and ABTS) with particular attention to the extract obtained with maceration. The Berberis hispanica Bois. and Reut. can serve society as it provides potentially bioactive compounds that may find application in the medical sector to control such diseases.

1. Introduction

Since ancient times, humans have developed natural products from plants, marine organisms, and microorganisms for various applications. Interest in natural resources goes back to over 1000 years [1]. Medicinal plants have been used for centuries as remedies, and continue to provide alternative agents to fight various devastating diseases [2,3]. Numerous drugs are derived from natural sources including medicinal plants, which can be available in the form of food supplements, nutraceuticals, and complementary alternative medicine [1]. Plants synthesize secondary metabolites with various chemical structures including tannins, terpenoids, alkaloids, and flavonoids, which are involved in several therapeutic pharmacological properties like antimicrobial, anti-oxidants, anticancer, and anti-inflammatory activities [2,4]. Medicinal plants are characterized in priority as an exhaustive source of bioactive compounds that are used in drug development [4,5].

The genus Berberis belongs to the family Berberidaceae with about 500 species. Berberis possesses many medicinal properties since it has been used in the treatment of diseases including leishmaniasis, heart disease, cholecystitis, hypertension, colds, cholelithiasis, dysentery, gallstones, digestive ailments, jaundice, malaria, ischemic heart disease, cardiomyopathies, and urinary tract problems [6,7,8,9,10]. The Spanish barberry is used in traditional medicine to cure gastrointestinal stones, inflammation, liver, and biliary disorders [11]. Genus Berberisis is rich in compounds including tamarixetin, rutin, caffeic, and chlorogenic acids with bioactivity potential. However, the available results on its chemical composition are more limited [10,12]. These compounds are responsible for Berberis biological activities such as antidepressant, antinociceptive, and immunomodulation effects [11,13].

Several works have reported that reactive oxygen species (ROS) are involved in cancer, meanwhile, antioxidant agents are used to counteract them. Plants have been found to contain significant ROS scavenging and antiproliferative activities toward cancer cells. Several studies have shown that plants serve as anticancer agents through apoptosis in numerous cancer cell lines [14].

The goal of this work was to study the phytochemical composition, antioxidant, and antiproliferative activities of Berberis hispanica Boiss. & Reut. (B. hispanica). These goals may open new approaches to valorize this species as a source of promising agents to fight such diseases.

2. Material and Methods

2.1. Preparation of Plant Extract

The plant was harvested in September from the region of Errachidia, Morocco. The botanical authentication was done by Dr. Fennan and given the voucher specimen of #LHE.11 before being deposited at the herbarium. The bark of B. hispanica roots was removed, washed, and dried in the shade at room temperature before being ground into a fine powder. Next, a total of 20 g of plant powder was extracted with 100 mL of methanol using two methods including Sand maceration. The Soxhlet was set to 46 °C for 6 h and the maceration was done at room temperature for 24 h. Afterward, the mixture was meticulously filtered using Whatman filter paper before being concentrated using a rotary evaporator. The extract obtained was then saved at 4 °C until further use.

2.2. Cell Cultures

Four cancer cell lines were selected for testing including prostate (LnCap and 22RV1) and breast (MDA-MB-231 and MCF-7), which were grown in RPMI (Roswell Park Memorial Institute) and DMEM Dulbecco’s Modified Eagle’s) medium, respectively. RPMI and DMEM media had 10% heat-inactivated fetal calf serum, antibiotics, and glutamine with 1% in each. Cell culture was incubated at 37 °C and 5% CO₂. Next, cells were washed by PBS followed by trypsin (Gibco, 0.25%) for being detached.

2.3. In Vitro Antiproliferative Activity Assay

The viability of cells was estimated based on cell metabolic activity using the MTT assay. Briefly, MDA-MB-231. MCF-7, LnCap, and 22 RV1 cells were adjusted at a density of around 8000 cells per well in plates. After 24 h, the culture medium was replaced with plant concentrations ranging from 4.68 to 150 μg/mL. Afterward, the plates were reincubated for 72 h. Next, 100 μL of culture medium was replaced with 10 μL of MTT reagent before the plates being incubated again for a further 4 h. Cell viability was assessed by measuring the absorbance at 450 nm. Mitomycin was used as a drug reference (positive control) and untreated cells were used as a negative control. The results were expressed as percentages of cell inhibition.

2.4. Determination of Phenolic Contents

Total phenolic contents (TPCs) were conducted using methods based on the Folin–Ciocalteu reagent by Spanos [15] with limited modifications. Briefly, 2.5 mL of 10% (v/v). Folin–Ciocalteu chemical was added to 0.5 mL of the sample solution. Next, the reaction was conducted at 45 °C for 30 min before 4 mL of 7.5% (w/v) Na₂CO₃ being added. The absorbance of the sample was read at 765 nm. TPCs were expressed as mg GGE/g extract.

2.5. Determination of Total Flavonoid Content

The total flavonoid content (TFCs) of B. hispanica extracts was assessed according to the method by Dewanto et al. (2002) [16] with limited modifications. Briefly, 1 mL of plant extract was mixed with 0.3 mL of NaNO₃ (5%) and 0.3 mL of 1% (w/v) AlCl₃. Next, 2 mL of 1 M NaOH was also added to the whole solution before being stirred and allowed to stand. The absorbance of the sample was read at 510 nm. TFCs were expressed as mg RE/g extract.

2.6. Evaluation of Antioxidant Activity

2.6.1. DPPH Radical Scavenging Assay

Radical scavenging activity of plant extracts was evaluated by using the DPPH assay as described by Sayah et al. (2017) [17]. Briefly, 2.5 mL of different plant concentrations were mixed with a solution of DPPH (0.2 mM of DPPH). The mixture was vigorously vortexed before being kept in the dark at room temperature for 30 min. Afterward, the absorbance of the sample was read at 517 nm. The antioxidant activity was expressed as a percentage of DPPH inhibition by using the following formula:

DPPH (%) = [(Abs_DPPH − Abs_Sample)/Abs_DPPH] ∗ 100

where Abs_DPPH is the absorbance of DPPH used for testing and Abs_sample is the absorbance of DPPH in the presence of the plant extract tested. The scavenging results were expressed as IC₅₀ (required concentration to inhibit 50% of free radicals).

2.6.2. Ferric Reducing Antioxidant Power (FRAP) Assay

The ferric-reducing capacity of B. hispanica was effectuated using the method of potassium ferricyanide-ferric chloride with limited changes [18]. Briefly, 1 mL of plant extract was added to a mixture including 2.5 mL of phosphate buffer (0.2 M, pH 6.6) and 2.5 mL of potassium ferricyanide (1%) and then incubated at 50 °C for 20 min. Next, 2.5 mL of 10% trichloroacetic acid was added to the final solution before being centrifuged at 3000 rpm for 1 min. Finally, 2.5 mL of the supernatant was added to 2.5 mL of distilled water with 0.5 mL FeCl3 (0.1%, w/v). The absorbance of the sample was read at 700 nm and the findings were expressed as mg AAE/g extract.

2.6.3. Trolox Equivalent Antioxidant Capacity (TEAC) Assay

TEAC was studied according to the previously reported protocol [18]. Briefly, ABTS radical solution was obtained by mixing 10 mL of 2 mM ABTS and 100 µL of 70 mM potassium persulfate at ambient temperature for 16 h. Next, the solution of ABTS∙+ was diluted in methanol to have an absorbance value of about 0.70 at 734 nm. The absorbance was read at 734 nm. Scavenge capability toward ABTS radical was assessed using the following equation:

ABTS scavenging effect (%) = ((A₀ − A₁)/A₀) × 100

where A₀ is the absorbance of the control solution and A₁ is the absorbance of the sample solution. Scavenging activity was expressed as IC₅₀.

2.7. Gas Chromatography-Mass Spectrometry Analysis

The gas chromatography-mass spectrometry analysis (GC-MS) technique was used in this study to identify phytocomponents present in the studied extract obtained by maceration. GC-MS characterization of the plant extract was conducted after methylation using a PerkinElmer Clarus 580 gas chromatograph equipped with a capillary column (5% phenyl, 95% methyplisyloxane; 30.0 MX 250 μm). Helium was used as a carrier gas at 1 mL/min. The split was 1/75 and the injection volume of the sample was 1 µL. The temperature of both injection and detection was set to 250 °C and 280 °C, respectively. The temperature of the furnace was programmed as follows: from 50 °C to 200 °C at a rate of 11 °C/min, then from 200 °C to 240 °C at a rate of 6 °C/min. The identification of phytocomponents was done by comparing the retention times with those of the references obtained from the database of the technique [5].

2.8. Statistical Analysis

Data were expressed as means ± standard deviation of triplicate assays using analysis of variance (ANOVA). Statistical analysis was conducted using GraphPad Prism 6. Values were statically considered significant at a p-value ≤ 0.05.

3. Results and Discussion

3.1. Total Phenolic and Flavonoids Contents

The phenolic and flavonoids contents were dosed using gallic acid and quercetin calibration curves (Figure 1 and Figure 2). The total phenol and total flavonoid contents are presented in

Table 1. Total phenolic and flavonoid contents in B. hispanica extracts.

	Methanol Extract
Berberis Hispanica	TPC (mg GAE/g Extract)		TFC (mg RE/g Extract)
	EMM	EMS	EMM	EMS
	321.56 ± 3.05	289.02 ± 2.32	118.4 ± 2.24	98.4 ± 2.56

EMM: Extracts obtained with maceration; EMS: Extracts obtained with Soxhlet. Values are expressed as means ± SD of triplicate assays.

. Even though the methanol fraction by maceration was found to be noticeably higher in TPC (321.56 ± 3.05 mg GAEs/g extract) and TFC (118.4 ± 2.24 REs/g extract), no statistically significant difference between the two extraction methods was found (p > 0.05). The extract obtained by the Soxhlet method was slightly lower in polyphenol (289.02 ± 2.32 GAEs/g) and flavonoids (98.4 ± 2.56 GAEs/g). The results obtained showed that B. hispanica is potentially rich in polyphenols and flavonoids with some differences resulting from the two methods of extraction used (maceration or Soxhlet).

3.2. Gas Chromatography-Mass Spectrometry (GC-MS) Analysis

The presence of chemical components in the methanol extract obtained by maceration of B. hispanica was identified by GC-MS after methylation. The results obtained showed that forty-five chemical compounds were identified in the extract (Figure 3;

Table 2. Chemical compounds identified in the methanol extract of B. hispanica bark.

	RT	Molecular Weight (g/mol)	Formula	Compound Name	Area (%)
1	3.80	100.16	C6H12O	Hexanal	4.542
2	3.84	100.16	C6H12O	2-Hexen-1-ol, (E)	4.542
3	4.36	130.23	C8H18O	1-Heptanol, 3-methyl	1.062
4	4.86	394.5	C23H26N2O4	N-(1-Hydroxy-4-oxo-1-phenylperhydroquinolizin-3-yl) carbamic acid, benzyl ester	1.075
5	5.78	130.23	C8H18O	3,4-Dimethyl-2-hexano	0.683
6	6.26	112.17	C7H12O	2-Heptenal, (Z)	2.608
7	6.38	414.4	C19H14F4O4S	Benzoic acid 3-methyl-4-(1,3,3,3-tetrafluoro-2-methoxycarbonyl-propenylsulfanyl)-phenyl ester	0.250
8	6.89	184.36	C13H28	2,5,6-Trimethyldecane	0.344
9	7.79	142.2	C7H15ClN2O	N-Methyl-3-piperidinecarboxamide	0.250
10	8.43	210.4	C15H30	2,4,6,8-Tetramethyl-1-undecene	0.552
11	9.17	186.33	C12H26O	1-Octanol, 2-butyl-	0.552
12	9.86	170.33	C12H26	Dodecane	0.698
13	10.0	166.26	C11H18O	1-Oxaspiro [2.2]pentane,5-isopropylidene-2,2,4,4-tetramethyl	0.344
14	10.77	154.25	C10H18O	2-Decenal, (Z)	0.438
15	11.21	152.23	C10H16O	2,4-Decadiena	2.340
16	11.50	152.23	C10H16O	2,4-Decadienal	3.786
17	11.67	138.21	C9H14O	2,4-Nonadienal	3.786
18	12.46	296.6	C21H44	Heptadecane,2,6,10,14-tetramethyl-	1.290
19	12.51	268.5	C19H40	2,3-Dimethylheptadecane	1.290
20	13.35	198.39	C14H30	Tetradecane	1.290
21	14.10	224.42	C16H32	7-Hexadecene, (Z)	0.276
22	14.77	226.41	C16H34	Hexadecane	1.266
23	14.84	184.37	C13H28	Tridecane	1.266
24	15.94	201.22	C12H11NO2	trans-Ethylalpha cyanocinnamate	0.313
25	16.84	186.33	C12H26O	2-Dodecanol	0.435
26	16.91	212.42	C15H32	Pentadecane	1.075
27	17.06	184.36	C13H28	2-Methyldodecane	1.075
28	18.04	256.42	C16H32O2	n-Hexadecanoicacid	1.993
29	18.84	280.5	C20H40	9-Eicosene, (E)	0.643
30	19.23	212.41	C15H32	Dodecane, 2,6,10-trimethyl	1.325
31	19.88	378.6	C21H34O4Si	Decan-2-yl trimethylsilyl phthalate 1,2 Benzenedicarboxylic acid	0.702
32	20.21	292.25	C16H11F3O2	1-fluorenecarboxylic acid, 2,2,2-trifluoroethyl ester	1.662
33	20.48	324.6	C23H48	Heptadecane, 9-hexyl	0.320
34	21.17	322.5	C21H38O2	11,14-Eicosadienoic acid, methyl ester	14.287
35	21.20	280.4	C18H32O2	Linoelaidic acid	14.287
36	21.71	254.5	C18H38	2,6,10-trimethyl-pentadecane	7.151
37	21.98	212.42	C15H32	Pentadecane	7.151
38	22.49	166.26	C11H18O	2,6-Nonadienal, 3,7-dimethyl	15.390
39	23.02	240.5	C17H36	Tetradecane, 2,6,10-trimethyl	3.445
40	23.58	272.9	C17H33	7-Heptadecene	15.390
41	24.07	100.16	C6H12O	2-Hexen-1-ol, (E)	0.514
42	24.56	118.17	C6H14O2	meso-3,4-Hexanediol	0.529
43	25.09	130.23	C8H18O	2-Hexanol, 3,4-dimethyl	0.683
44	25.64	112.17	C7H12O	2-Heptenal, (E)	0.324
45	26.15	170.33	C12H26	Dodecane	0.698

), among them 2-heptenal, (Z); 2,4-decadiena; 2,4-decadienal; heptadecane; 2,6,10,14-tetramethyl; hexadecane; and 11,14-eicosadienoic acid methyl ester were the chief chemical compounds in the plant extract. The findings of chemical analysis obtained with GC-MS displayed in Table 2 agreed with the results of the total polyphenolic and flavonoid contents presented in Table 1, since both affirm the presence of common chemical classes.

It has been reported in different studies that the pharmacological activities of B. hispanica are related to its chemical composition, especially alkaloid and polyphenol classes. The chemical characterization of B. hispanica extracts investigated in this work showed the presence of various compounds belonging to these families in the methanolic extracts, which are probably responsible for the antioxidant and antiproliferative activities of the studied plant. The chemical analysis affirmed the presence of many phenolic compounds in the extract like N-(1-Hydroxy-4-oxo-1-phenylper hydroquinolizin-3-yl) carbamic acid, benzyl ester; benzoic acid 3-methyl-4-(1,3,3,3-tetrafluoro-2-methoxycarbonyl-propenylsulfanyl)-phenylester, and Decan-2-yl trimethylsilyl phthalate 1,2 Benzenedicarboxylic acid. Therefore, we can confirm that the chemical content of the studied plant is strongly correlated to the biological outcomes.

It was demonstrated that the rutin and tamarixetin contained in Berberis were responsible for the inhibition of cancer cell lines in a concentration-or time-dependent manner by inducing apoptosis and blocked cell cycle progression at the G2-M phase [10]. Anti-proliferative activity in breast (MCF-7), colon (Caco-2), and pancreas (BxPC-3) cancer cell lines induced by Genus berberis was well reported elsewhere (21). Moreover, rutin exhibited a dose-or time-dependent inhibitory effect on U-937 and HT-60 and glioma human cancer cell lines [12,19,20,21,22]. Fernández-Poyatos et al. (2020) [12] reported that the most abundant compounds found in B. hispanica are phenolic acids, primarily chlorogenic acid and other caffeoylquinic acids. These compounds have been reported to have antioxidant effects [10,23]. Moreover, these compounds have also been shown to possess an in vivo and in vitro anticancer activity in various cancerous cell lines including MCF-7, HCT-116, Hep-G2, and PC-3. Some compounds from caffeoylquinic acids were reported to have an inhibitory effect on the stomach (KatoIII), colon (DLD-1), and promyelocytic leukemia cancer cell lines (HL-60) [24,25].

The results obtained in this work showed that B. hispanica possesses interesting antioxidant and antiproliferative activities, which can be explained by its richness in phenolic, alkaloids, and other potentially bioactive compounds. This species appears to be an interesting source of various compounds, which can be applied in medicines to fight such diseases.

3.3. Antioxidant Activity

In the current work, plant extracts were tested for their antioxidant capacity using different tests including DPPH, ABTS radical scavenging capacity, and FRAP (

Table 3. Antioxidant activity of B. hispanica by DPPH, FRAP, and ABTS.

	DPPH (IC50 in mg/mL)	ABTS (mg TE/g Extract)	FRAP (mg AAE/g Extract)
EMS	0.210 ± 0.017	56.564 ± 1.63	79.4 ± 0.45
EMM	0.180 ± 0.020	60.203 ± 0.76	80.066 ± 3.28
BHT	0.029 ± 0.006
Ascorbic acid	0.007 ± 0.001
Trolox	1.93 ± 0.05

EMM: Extracts obtained with maceration; EMS: Extracts obtained with Soxhlet.

). The results of the DPPH test showed that the extract tested had scavenging activity in a dose-dependent manner. The extracts showed a potent antioxidant activity, especially that obtained by maceration extract with IC₅₀ = 0.180 ± 0.020 mg/mL when compared to the one obtained by Soxhlet extraction (IC₅₀ = 0.210 ± 0.017 mg/mL), however, no significant difference was observed between the two methods (p > 0.05).

Regarding the FRAP bioassay, the highest reducing power was interestingly observed with the maceration extract (80.066 ± 3.28 AAE/g extract) when compared to the one obtained by the Soxhlet method (79.4 ± 0.45 mg AAE/g extract). In these tests, B. hispanica revealed interesting antioxidant activity with insignificant differences between the two methods of extraction.

For the antioxidant activity measured by the ABTS method, we noted that both extracts exhibited potent antioxidant activity in a dose-dependent manner in the DPPH test. The ability of the extracts to scavenge the ABTS cation is presented in Table 2. The B. hispanica extract obtained by maceration showed the highest antioxidant ability (60.203 ± 0.76 mg TE/g extract) when compared with the Soxhlet extract (56.564 ± 1.63 mg TE/g extract).

The obtained results showed that the plant possessed potent antioxidant activity with IC₅₀ = 0.180 ± 0.020 mg/mL for the extract obtained by maceration, and IC₅₀ = 0.210 ± 0.017 mg/mL for the Soxhlet extract in the DPPH assay. In the present work, we used different methods to evaluate the antioxidant potential of B. hispanica methanolic extract; using the ATBS bioassay, maceration, and Soxhlet extracts showed values of 60.203 ± 0.76 mg TE/g and 56.564 ± 1.63 TE/g extract, respectively. The FRAP assay showed that maceration and Soxhlet extracts scored values of 80.066 ± 3.28 mg AAE/g extract and 79.4 ± 0.45 mg AAE/g extract, respectively. These results were in close accordance with those reported by Fernández-Poyatos et al. (2020) [12], who revealed that methanolic and aqueous extracts from Spanish species exhibited antioxidant activity with 648 and 212 mmol Trolox equivalent g⁻¹ dried extracts, respectively.

These three methods differ from each other due to characteristics such as substrate type, reaction conditions, and data quantitation methods [18]. A complete picture of the total antioxidant capacity of the methanol extracts from B. hispanica was obtained via analysis of FRAP, DPPH, and ABTS, which showed that studied plant extracts can show different antioxidant power.

3.4. In Vitro Antiproliferative Activity Assay

The MTT assay revealed that B. hispanica extracts have a potent antiproliferative effect on both breast and prostate cancer cells in a dose-dependent manner after 72 h of treatment (Figure 4 and Figure 5;

Table 4. IC₅₀ values of B. hispanica extracts in MDA MB-231, MCF7, LnCap, and 22rv cell lines.

	MDA-MB-231	MCF-7	22 RV-1	LnCap
EMM (µg/mL)	16.55 ± 0.58	17.95 ± 0.58	11.75 ± 0.35	11.91 ± 0.54
EMS (µg/mL)	19.93 ± 0.74	20.22 ± 0.89	13.47 ± 0.52	19.64 ± 1.05

EMM: Extracts obtained with maceration; EMS: Extracts obtained with Soxhlet.

). The cytotoxic effect of extracts on the morphology of cancer cells tested can be observed under the phase-contrast inverted microscope after cell incubation with different concentrations of plant extracts. Treatment of breast (MDA-MB-231, MCF-7) and prostate (22-RV, LnCap) human cancer cell lines for 72 h with increasing concentrations of extracts from B. hispanica induced morphological changes (cancer cell detached as well as the loss of anchor properties) when compared to untreated cells (cancer cells attached to neighbors with preservation of anchor properties) revealing that all lines underwent cell death (Figure 4 and Figure 5).

The methanolic extract showed higher antiproliferative activity in both breast and prostate cancer cell lines (Figure 4 and Figure 5; Table 4). Indeed, in breast cancer cell lines MDA-MB-231 and MCF-7, the IC₅₀ values obtained by the maceration extract were 16.55 ± 0.58 µg/mL and 17.95 ± 0.58 µg/mL, respectively. The values were slightly lower than the IC₅₀ values obtained with the Soxhlet extract MDA-MB-231 (19.93 ± 0.74 µg/mL) and MCF-7 (20.22 ± 0.89 µg/mL). Regarding prostate cancer cells 22 RV and LnCap, the IC₅₀ values obtained by the maceration extract (22 RV: 11.75 ± 0.35 µg/mL; LnCap: 11.91 ± 0.54 µg/mL) were also lower than those obtained with Soxhlet (22 RV: 13.47 ± 0.52 µg/mL; LnCap: 19.64 ± 1.05 µg/mL). Even though the maceration extract was found better in reducing cell viability in cancer cell lines, the two extracts (maceration and Soxhlet) did not differ significantly (p > 0.05).

The results obtained demonstrated that the studied extract possessed antiproliferative potential against the various cell lines resulting in the inhibition of cell proliferation in a dose-dependent manner. In breast cancer cell lines MDA-MB-231 and MCF-7, the IC₅₀ values obtained by maceration were 16.55 ± 0.58 and 17.95 ± 0.58 µg/mL, respectively, which were slightly lower than those obtained with the Soxhlet extract MDA-MB-231; 19.93 ± 0.74 µg/mL and MCF-7; 20.22 ± 0.89 µg/mL. Regarding prostate cancer cells 22 RV1 and LnCap, the IC₅₀ values obtained by the maceration extract (22 RV1: 11.75 ± 0.35 µg/mL; LnCap: 11.91 ± 0.54 µg/mL) were also lower than those obtained with Soxhlet (22 RV1: 13.47 ± 0.52 µg/mL; LnCap: 19.64 ± 1.05 µg/mL). Therefore, we can confirm that our extract of B. hispanica possesses an important anti-proliferative activity against different cancerous cell lines. These results agree with those reported in the literature, which showed that genus Berberis contained tamarixetin, rutin, and caffeic acid, all known for their cytotoxic effects against cancer cell lines including HeLa cells with IC₅₀ > 100 µg/mL. Moreover, the alkaloid extract from indigenous species to Algeria induced cell death and morphological changes [13,19].

4. Conclusions

B. hispanica is a medicinal plant among the family Berberidaceae that has been found to have pharmacological potential as reported in several previous studies. This work was intended to study the chemical profile, antiproliferative, and antioxidant activities of the organic extracts obtained with two different methods of extractions including maceration and Soxhlet. Based on the findings obtained, the studied plant exhibited potent antioxidant and antiproliferative activity toward human prostate and breast cancer cell lines. Moreover, our results showed that both methods of extraction were closely similar in terms of the activities studied, and therefore, did not differ significantly. B. hispanica can serve society as it provides potentially active compounds that may find applications in medical sectors to control such diseases.